Expanded Access & Compassionate Use
Patients facing serious illnesses who have exhausted all available treatment options often want to know if and how they can receive early access to investigational drugs that haven’t yet been approved by government regulatory agencies. The information below explains options that may be available to patients in these circumstances.
Clinical Trials
For new medicines and vaccines to be legally approved for use, companies like Pfizer are required to evaluate their safety and effectiveness in clinical trials and submit trial results to regulatory agencies. To participate in a trial, you must meet certain criteria. For those who meet the criteria to join a clinical trial, participation offers the chance to contribute to medical research that may benefit many others. Participation in a clinical trial comes with certain risks; that is why patient "informed consent" is a required step in the process of enrolling.
- Learn more about clinical trials
- Find a Pfizer clinical trial
- Search for open recruiting trials by the investigational drug name or therapeutic area
- Find a trial on clinicaltrials.gov (all sponsors, including Pfizer Inc.)
Expanded Access or Compassionate Use
In cases where a clinical trial isn’t an option, and the patient has exhausted all available treatment options, regulators/health authorities may grant permission for us to provide a treating physician with an investigational drug pre-approval. Such individual use of an investigational drug pre-approval is often called "expanded access" or "compassionate use" but may go by other names. Pfizer refers to these requests as expanded access.
Inquire about expanded access of a Pfizer investigational or pre-approval drug
It’s important to remember that investigational drugs have not yet received regulatory approval; therefore, their potential risks and benefits are not yet established. Doctors and patients should consider all possible benefits and risks when seeking expanded access to an investigational drug.
Please feel free to contact us with any questions.
June Social Media Round-Up—2025 Impact Report, ADA 2026, and More
School is out for the summer, but Pfizer colleagues are still hard at work.
Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business
Here at Pfizer, we are in the business of breakthroughs, and while our focus is on making advancements that impact patients’ lives, we are also aware of our work’s broader impact on the world.
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Read the full report. Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by Τhe Pfizer Multicultural Health Equity Collective (The Collective).These on-the-ground, gr
Pfizer’s 2024 Impact Report Highlights Accomplishments in Sustainability, Responsibility
When Pfizer talks about making breakthroughs that change patients’ – and people’s – lives, we aren’t simply referring to scientific discovery and game-changing medicines.
Pfizer’s Statement on Results of Sixth Annual Pay Equity Study Among Colleagues Worldwide
NEW YORK, N.Y., February 25, 2025 – Pfizer Inc.
Pfizer Awards 1ドル.75 Million to Support Community Forward Solutions to Address Health Disparities
To help address systemic health disparities, The Pfizer Multicultural Health Equity Collective (The Collective) is awarding 1ドル.75 million to seven U.S.
Living Our Values Through Pfizer’s Refugee Initiatives
According to the United Nations, 120 million people are expected to be forcibly displaced worldwide by 2025. This is a record level of displacement.
Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism
Left to right: Dave Denton and Pfizer colleagues packing "Cheer kits" for veterans in the New York regionBuilding on Pfizer’s 175-year legacy to be a force for good in the world, Pfizer has launched 175 Days of Good—a global call to action to inspire and celebrate colleague volunteerism and Pfizer’s
2023 In Review
At Pfizer, we are working tirelessly to outdo yesterday by bringing new breakthroughs to patients around the globe in innovative ways. As we do this, it’s important that we take the time to reflect on both our challenges and our achievements.
Pfizer’s Statement on Results of Fifth Annual Pay Equity Study Among Colleagues Worldwide
NEW YORK, N.Y., February 23, 2024 – Pfizer Inc.
Pfizer Accelerates Climate Action through Pan-European Virtual Power Purchase Power Agreements
The impact of climate change on human health is unequivocal.
October Social Media Round-Up—Israel-Hamas War, COVID-19 Treatment News, and Pfizer Makes Forbes List
October was an eventful month, both around the world and here at Pfizer.
Accelerating Equity Takes the Spotlight at Pfizer’s Global DEI Summit
On September 21, over 7,000 Pfizer colleagues and external DEI experts came together at Pfizer NYC headquarters and via webcast for the 2023 Pfizer Global DEI Summit.
Pfizer’s Rocky Mount Facility Restarts Production Amid First Phase of Post-Tornado Recovery Efforts
NEW YORK, September 25, 2023 – Pfizer Inc. (NYSE: PFE) has restarted the majority of its manufacturing lines at the Rocky Mount, North Carolina facility following severe damage from a tornado that hit the site on July 19.
Bringing Together Diverse Organizations to Strive for Health Equity
As a Black woman who grew up living in subsidized housing in the U.S., I know what it means to live in a world where healthcare is not equal, and not trusted.
Improving COVID-19 Vaccine Access in Partnership with Amref Health Africa
A community member while receiving a COVID-19 vaccine in Uganda. Photo credit: Amref Health Africa.More than three years into the pandemic, for some, access to care to help prevent COVID-19 may only mean a 10-minute trip to a doctor's office or pharmacy.
Pfizer Statement on Results of Fourth Annual Pay Equity Study Among Colleagues Worldwide
NEW YORK, N.Y., February 28, 2023 – Pfizer Inc.
Three Principles of Responsibility for Artificial Intelligence (AI) in Healthcare
Most people already use artificial intelligence (AI) in their daily lives, sometimes without even thinking about it as being AI-driven.
A Billion Doses Delivered: 3 Lessons from the Fight Against Trachoma
Credit: Brent Stirton/Getty Images for ITI Imagine an infection that causes your eyelids to turn inward, so that your lashes—intended to protect your eyes—scrape against the sensitive outer surface of your eye every time you blink. The pain is excruciating and constant. Your eyes water.